Neoadjuvant Radiation Lobectomy and Immunotherapy for Angioinvasive HCC Resulting in Complete Pathologic Response

Hepatology. 2021 Jul;74(1):525-527. doi: 10.1002/hep.31675. Epub 2021 Apr 27.

Authors

Harris Liou¹, Kabir Mody², Ashton W Boyle², Andrew P Keaveny³, Kristopher P Croome³, Justin M Burns³, Denise M Harnois³, Tushar C Patel³, Beau Toskich⁴

Affiliations

¹ Alix School of Medicine, Mayo Clinic, Scottsdale, AZ.
² Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL.
³ Department of Transplantation, Mayo Clinic, Jacksonville, FL.
⁴ Department of Radiology, Mayo Clinic, Jacksonville, FL.

PMID: 33615518
DOI: 10.1002/hep.31675

No abstract available

Publication types

Case Reports

MeSH terms

Ablation Techniques / methods
Aged
Biopsy
Carcinoma, Hepatocellular / pathology
Carcinoma, Hepatocellular / therapy*
Chemoradiotherapy, Adjuvant / methods*
Hepatectomy
Humans
Immune Checkpoint Inhibitors / administration & dosage
Liver / blood supply
Liver / radiation effects
Liver / surgery*
Liver Neoplasms / pathology
Liver Neoplasms / therapy*
Male
Microspheres
Middle Aged
Neoadjuvant Therapy / methods*
Neoplasm Invasiveness
Nivolumab / administration & dosage
Treatment Outcome
Yttrium Radioisotopes / administration & dosage

Substances

Immune Checkpoint Inhibitors
Yttrium Radioisotopes
Yttrium-90
Nivolumab